Search Within

Bone Marrow Transplant

Formats
  1. Meeting Abstract (1531)
  2. Journal Article (1198)
  3. Review (75)
  4. Research Letter (49)
  5. Book Section (34)
  6. Guidelines (26)
  7. Editorial (24)
  8. Correspondence (18)
  9. Conference Paper (14)
  10. Book Whole (1)
  11. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (2971)
  2. Department of Medicine (2971)
  3. Hematologic Malignancies, Division of (2848)
  4. Survivorship Research (1389)
  5. GSK Faculty (931)
  6. CTCR Scholars (874)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (943)
  3. Sean Devlin (470)
  4. Ann Jakubowski (459)
  5. Gunjan Shah (447)
  6. Heather Landau (436)

More People

Years
  1. 2025 (68)
  2. 2024 (212)
  3. 2023 (263)
  4. 2022 (201)
  5. 2021 (177)
  6. 2020 (208)

More Years

Publications
  1. Blood (887)
  2. Biology of Blood and Marrow Transplantation (516)
  3. Bone Marrow Transplantation (175)
  4. Journal of Clinical Oncology (127)
  5. Transplantation and Cellular Therapy (113)
  6. Blood Advances (95)

More Publications

Publishers
  1. American Society of Hematology (989)
  2. Elsevier Inc. (767)
  3. Nature Publishing Group (261)
  4. American Society of Clinical Oncology (130)
  5. Wiley Blackwell (66)
  6. Taylor & Francis Group (65)

More Publishers

Results (2971)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A multicenter retrospective analysis of outcomes and toxicities with commercial axicabtagene ciloleucel and tisagenlecleucel for relapsed/refractory aggressive B-cell lymphomas
    Meeting Abstract

    Riedell, P. A.; Walling, C.; Nastoupil, L. J.; Pennisi, M.; Maziarz, R. T.; McGuirk, J. P.; Oluwole, O. O.; Bachanova, V.; Hwang, W. T.; Schuster, S. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Targeted conditioning with anti-CD45 iodine (I-131) apamistamab [Iomab-B] leads to high rates of allogeneic transplantation and successful engraftment in older patients with active, relapsed or refractory (rel/ref) AML after failure of chemotherapy and targeted agents: Preliminary midpoint results from the prospective, randomized phase 3 SIERRA trial
    Meeting Abstract

    Gyurkocza, B.; Nath, R.; Stiff, P. J.; Agura, E.; Litzow, M. R.; Tomlinson, B.; Choe, H.; Abhyankar, S.; Seropian, S. E.; Chen, G. L.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • An alpha-defensin gene single nucleotide polymorphism modulates the gut microbiota and may alter the risk of acute graft-versus-host disease
    Meeting Abstract

    Rashidi, A.; Herman, A.; Gomes, A.; Peled, J. U.; Jenq, R. R.; Staley, C.; Blazar, B. R.; Weisdorf, D. J.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Addition of tocilizumab to cyclosporine-a/ mycophenolate mofetil (CSA/MMF) graft-vs-host disease (GVHD) prophylaxis significantly abrogates pre-engraftment syndrome (PES) & severe acute GVHD after adult double unit cord blood transplantation (dCBT)
    Meeting Abstract

    Politikos, I.; Maloy, M. A.; Devlin, S. M.; Naputo, K.; Bhatt, V.; Skinner, K.; Cho, C.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Time to relapse and the patterns of relapse are prognostic for post-relapse survival after CD34(+)-selected allogeneic hematopoietic stem cell transplantation in multiple myeloma
    Meeting Abstract

    Gomez-Arteaga, A.; Shah, G. L.; Baser, R. E.; Ruiz, J. D.; Bryant, A.; Chung, D. J.; Dahi, P. B.; Ghosh, A.; Lahoud, O. B.; Landau, H. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Difference in involved and uninvolved free light chain (dFLC) of less than 1mg/dL early post risk adapted melphalan and autologous stem cell transplantation (RA-ASCT) predicts renal response (RR) at 1 year in light chain (AL) amyloidosis
    Meeting Abstract

    Purvey, S.; Seier, K.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Shah, G. L.; Hassoun, H.; Giralt, S. A.; Landau, H. J.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Daratumumab-based regimen in treating clonal plasma cell neoplasms in solid organ transplant recipients
    Journal Article

    Chaulagain, C. P.; Diacovo, J. M.; Elson, L.; Comenzo, R. L.; Samaras, C.; Anwer, F.; Khouri, J.; Landau, H.; Valent, J.
    Clinical Lymphoma, Myeloma and Leukemia (2020)

    Fulltext@MSK | Save
  • Maintenance therapy and need for cessation studies in multiple myeloma: Focus on the future
    Review

    Diamond, B.; Maclachlan, K.; Chung, D. J.; Lesokhin, A. M.; Landgren, C. O.
    Best Practice and Research: Clinical Haematology (2020)

    Fulltext@MSK | Save
  • Reduction of opioid use by acupuncture in patients undergoing hematopoietic stem cell transplantation: Secondary analysis of a randomized, sham-controlled trial
    Journal Article

    Deng, G.; Giralt, S.; Chung, D. J.; Landau, H.; Siman, J.; Li, Q. S.; Lapen, K.; Mao, J. J.
    Pain Medicine (2020)

    Fulltext@MSK | Save